356 related articles for article (PubMed ID: 10773883)
1. GA-binding protein alpha/beta is a critical regulator of the BRCA1 promoter.
Atlas E; Stramwasser M; Whiskin K; Mueller CR
Oncogene; 2000 Apr; 19(15):1933-40. PubMed ID: 10773883
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
Williamson EA; Wolf I; O'Kelly J; Bose S; Tanosaki S; Koeffler HP
Oncogene; 2006 Mar; 25(9):1391-9. PubMed ID: 16331276
[TBL] [Abstract][Full Text] [Related]
3. A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element.
Atlas E; Stramwasser M; Mueller CR
Oncogene; 2001 Oct; 20(48):7110-4. PubMed ID: 11704836
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a negative transcriptional element in the BRCA1 promoter.
MacDonald G; Stramwasser M; Mueller CR
Breast Cancer Res; 2007; 9(4):R49. PubMed ID: 17663789
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein.
Imaki H; Nakayama K; Delehouzee S; Handa H; Kitagawa M; Kamura T; Nakayama KI
Cancer Res; 2003 Aug; 63(15):4607-13. PubMed ID: 12907639
[TBL] [Abstract][Full Text] [Related]
6. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
7. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
Chai Y; Chipitsyna G; Cui J; Liao B; Liu S; Aysola K; Yezdani M; Reddy ES; Rao VN
Oncogene; 2001 Mar; 20(11):1357-67. PubMed ID: 11313879
[TBL] [Abstract][Full Text] [Related]
8. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
9. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
10. Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.
Chen S; Ye J; Kijima I; Kinoshita Y; Zhou D
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):17-23. PubMed ID: 15955695
[TBL] [Abstract][Full Text] [Related]
11. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
[TBL] [Abstract][Full Text] [Related]
12. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer.
Antonova L; Mueller CR
Genes Chromosomes Cancer; 2008 Apr; 47(4):341-52. PubMed ID: 18196591
[TBL] [Abstract][Full Text] [Related]
13. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
14. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach.
Beger C; Pierce LN; Kruger M; Marcusson EG; Robbins JM; Welcsh P; Welch PJ; Welte K; King MC; Barber JR; Wong-Staal F
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):130-5. PubMed ID: 11136250
[TBL] [Abstract][Full Text] [Related]
15. Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.
Lu M; Arrick BA
Oncogene; 2000 Dec; 19(54):6351-60. PubMed ID: 11175350
[TBL] [Abstract][Full Text] [Related]
16. The NRF-1/alpha-PAL transcription factor regulates human E2F6 promoter activity.
Kherrouche Z; De Launoit Y; Monte D
Biochem J; 2004 Nov; 383(Pt. 3):529-36. PubMed ID: 15257658
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
18. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.
Wang HH; Chiang AN
Biochem J; 2004 Jun; 380(Pt 2):455-63. PubMed ID: 14984368
[TBL] [Abstract][Full Text] [Related]
20. Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways.
Barth N; Langmann T; Schölmerich J; Schmitz G; Schäffler A
Diabetologia; 2002 Oct; 45(10):1425-33. PubMed ID: 12378384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
